Instituto Tumori Giovanni Paolo II-ONCOLOGIA MEDICA ( Site 2604)
Bari 70124
0 studies enrolling now ยท 1 studies all time
What they study most
Endometrial Cancer
Studies at this site
- Sacituzumab Tirumotecan (MK-2870) in Post Platinum and Post Immunotherapy Endometrial Cancer (MK-2870-005) โ Running, not enrolling